<?xml version="1.0" encoding="UTF-8"?>
<ref id="B46-pathogens-09-00148">
 <label>46.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ma</surname>
    <given-names>J.K.C.</given-names>
   </name>
   <name>
    <surname>Drossard</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Lewis</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Altmann</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Boyle</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Christou</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Cole</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Dale</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>van Dolleweerd</surname>
    <given-names>C.J.</given-names>
   </name>
   <name>
    <surname>Isitt</surname>
    <given-names>V.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants</article-title>
  <source>Plant Biotechnol. J.</source>
  <year>2015</year>
  <volume>13</volume>
  <fpage>1106</fpage>
  <lpage>1120</lpage>
  <pub-id pub-id-type="doi">10.1111/pbi.12416</pub-id>
  <?supplied-pmid 26147010?>
  <pub-id pub-id-type="pmid">26147010</pub-id>
 </element-citation>
</ref>
